We aimed to elucidate whether this LTR–RIG-I axis regulates both the cellular immune response and the antitumour immune reaction by in vitro cell line experiments and ex vivo experiments using human peripheral blood mononuclear cells (PBMCs) and the analysis of cancer tissue from patients undergoing RT. This evidence concerns the gene RIGI and cancer.